We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




SNP Genotyping Platform Accurately Identifies Rare Donor Blood Types

By Labmedica staff writers
Posted on 10 Jul 2008
A single nucleotide polymorphism (SNP) genotyping platform enables faster screening for accurate identification of rare donor blood types. More...


There are many antigens located on the outer surface of the erythrocyte. Combinations of these blood group antigens vary between individuals even within the same A, B, or O blood type. The specificity of the antibodies in a recipient's blood and the prevalence of antigens in the donor population complicate the task of locating appropriate donors.

The OpenArray SNP genotyping platform, based on through-hole nanoliter fluidics technology, allows scientists to conduct up to 3,072 independent polymerase chain reaction (PCR) analyses simultaneously on a thin metal plate the size of a microscope slide. Developed by BioTrove (Woburn, MA, USA) the genotyping platform expands the capabilities of PCR.

BioTrove Inc. and BloodCenter of Wisconsin (Milwaukee, WI, USA) are collaborating to develop single SNP genotyping as a screening tool for identification of better-matched blood for transfusion. They will use the BioTrove OpenArray system to conduct erythrocyte genotyping more quickly and more economically. BloodCenter of Wisconsin will be able to stratify blood donors based on genotypic characteristics, improving the speed and accuracy of blood transfusions for patients in need.

BloodCenter's diagnostic laboratories develop and perform highly specialized tests on patient samples from throughout the United States and the world. The specialized testing and medical consultation provided by the diagnostic laboratories benefit patients in need of bone marrow or organ transplants, patients with bleeding and clotting disorders, and patients with immunologic, neoplastic, or genetic diseases.


Related Links:
BioTrove
BloodCenter of Wisconsin

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.